Effects of hormonal contraceptive use on HIV acquisition and transmission among HIV-discordant couples

AIDS

Volumn 27, Issue SUIPPL.1, 2013, Pages

  Lutalo, Tom ^a   Musoke, Richard ^a   Kong, Xiangrong ^b   Makumbi, Fred ^a,c   Serwadda, David ^a,c   Nalugoda, Fred ^a   Kigozi, Godfrey ^a   Sewankambo, Nelson ^a,d   Sekasanvu, Joseph ^a   Wawer, Maria ^b   Gray, Ronald ^b  

^a RAKAI HEALTH SCIENCES PROGRAM   (Uganda)

^b JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

^c MAKERERE UNIVERSITY SCHOOL OF PUBLIC HEALTH   (Uganda)

^d MAKERERE UNIVERSITY COLLEGE OF HEALTH SCIENCES   (Uganda)

Author keywords

discordant couples; HIV acquisition; HIV transmission; hormonal contraceptives; viral loads

Indexed keywords

ANTI HUMAN IMMUNODEFICIENCY VIRUS AGENT; CONTRACEPTIVE AGENT; LEVONORGESTREL; MEDROXYPROGESTERONE ACETATE;

ADULT; AGE DISTRIBUTION; ARTICLE; CONDOM; CONTROLLED STUDY; FEMALE; GYNECOLOGICAL AND OBSTETRIC IMPLANT; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HORMONAL CONTRACEPTION; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MAJOR CLINICAL STUDY; MALE; ORAL CONTRACEPTION; ORAL CONTRACEPTIVE USE; PRIORITY JOURNAL; RETROSPECTIVE STUDY; RISK ASSESSMENT; SEX DIFFERENCE; VIRUS LOAD; VIRUS TRANSMISSION;

ADOLESCENT; ADULT; COHORT STUDIES; CONTRACEPTIVE AGENTS, FEMALE; CONTRACEPTIVES, ORAL; FAMILY CHARACTERISTICS; FEMALE; HIV INFECTIONS; HUMANS; INCIDENCE; LEVONORGESTREL; MALE; MEDROXYPROGESTERONE ACETATE; MIDDLE AGED; RETROSPECTIVE STUDIES; RISK ASSESSMENT; UGANDA; YOUNG ADULT;

EID: 84885627652     PISSN: 02699370     EISSN: 14735571     Source Type: Journal    
DOI: 10.1097/QAD.0000000000000045     Document Type: Article

References (34)

1. Darroch JE, Sedgh G, Ball H. Contraceptive technologies: responding to women's needs. New York: Guttmacher Institute; 2011.
2. United Nations DoEaSA. World Contraceptive Use 2011. New York: United Nations; 2011.
3. Morrison CS, Skoler-Karpoff S, Kwok C, Chen PL, van de Wijgert J, Gehret-Plagianos M, et al. Hormonal contraception and the risk of HIV acquisition among women in South Africa. Aids 2012; 26:497-504.
4. Wand H, Ramjee G. The effects of injectable hormonal contraceptives on HIV seroconversion and on sexually transmitted infections. Aids 2012; 26:375-380.
5. Feldblum PJ, Lie CC, Weaver MA, Van Damme L, Halpern V, Adeiga A, et al. Baseline factors associated with incident HIV and STI in four microbicide trials. Sex Transm Dis 2010; 37:594-601.
6. Morrison CS, Chen PL, Kwok C, Richardson BA, Chipato T, Mugerwa R, et al. Hormonal contraception and HIV acquisition: reanalysis using marginal structural modeling. AIDS 2010; 24:1778-1781.
7. Myer L, Denny L, Wright TC, Kuhn L. Prospective study of hormonal contraception and women's risk of HIV infection in South Africa. Int J Epidemiol 2007; 36:166-174.
8. Baeten JM, Benki S, Chohan V, Lavreys L, McClelland RS, Mandaliya K, et al. Hormonal contraceptive use, herpes simplex virus infection, and risk of HIV-1 acquisition among Kenyan women. Aids 2007; 21:1771-1777.
9. Baeten JM, Lavreys L, Overbaugh J. The influence of hormonal contraceptive use on HIV-1 transmission and disease progression. Clin Infect Dis 2007; 45:360-369.
10. Kapiga SH, Lyamuya EF, Lwihula GK, Hunter DJ. The incidence of HIV infection among women using family planning methods in Dar es Salaam, Tanzania. Aids 1998; 12:75-84.
11. Kilmarx PH, Limpakarnjanarat K, Mastro TD, Saisorn S, Kaewkungwal J, Korattana S, et al. HIV-1 seroconversion in a prospective study of female sex workers in northern Thailand: continued high incidence among brothel-based women. Aids 1998; 12:1889-1898.
12. Lavreys L, Baeten JM, Martin HL Jr, Overbaugh J, Mandaliya K, Ndinya-Achola J, et al. Hormonal contraception and risk of HIV-1 acquisition: results of a 10-year prospective study. Aids 2004; 18:695-697.
13. Morrison CS, Richardson BA, Mmiro F, Chipato T, Celentano DD, Luoto J, et al. Hormonal contraception and the risk of HIV acquisition. Aids 2007; 21:85-95.
14. Polis C, Curtis K. Hormonal contraception and HIV acquisition in women: a systematic review of the epidemiological evidence. XIX International AIDS Conference; 2012; Washington DC.
15. Kiddugavu M, Makumbi F, Wawer MJ, Serwadda D, Sewankambo NK, Wabwire-Mangen F, et al. Hormonal contraceptive use and HIV-1 infection in a population-based cohort in Rakai, Uganda. Aids 2003; 17:233-240.
16. McCoy S, Zheng W, Montogmery E, Blanchard K, van den Straten A, Bruyn G, Padian N. Oral and injectable contraception use and risk of HIV acquisition among women: MIRA study. 19th Conference on Retroviruses and Opportunistic infections; 2012; Seattle.
17. Heffron R, Donnell D, Rees H, Celum C, Mugo N, Were E, et al. Use of hormonal contraceptives and risk of HIV-1 transmission: a prospective cohort study. Lancet Infect Dis 2012; 12: 19-26.
18. Gray RH. Use of hormonal contraceptives and risk of HIV-1 transmission. Lancet Infect Dis 2012; 12:507author reply 10-1.
19. Shelton JD. Use of hormonal contraceptives and risk of HIV-1 transmission. Lancet Infect Dis 2012; 12:507-508author reply 10-1.
20. Hubacher D. Use of hormonal contraceptives and risk of HIV-1 transmission. Lancet Infect Dis 2012; 12:508author reply 10-1.
21. Cushman LF, Romero D, Kalmuss D, Davidson AR, Heartwell S, Rulin M. Condom use among women choosing long-term hormonal contraception. Fam Plann Perspect 1998; 30:240-243.
22. Sangi-Haghpeykar H, Posner SF, Poindexter AN 3rd. Consistency of condom use among low-income hormonal contraceptive users. Perspect Sex Reprod Health 2005; 37:184-191.
23. WHO. Hormonal contraception and HIV technical statement:.-World Health Organization; 2012.
24. CDC. Update to CDC's U. S. Medical Eligibility Criteria for Contraceptive Use, 2010: revised recommendations for the use of hormonal contraception among women at high risk for HIV infection or infected with HIV. MMWR Morb Mortal Wkly Rep 2012; 61:449-452.
25. Gray RH, Li X, Kigozi G, Serwadda D, Brahmbhatt H, Wabwire-Mangen F, et al. Increased risk of incident HIV during pregnancy in Rakai, Uganda: a prospective study. Lancet 2005; 366:1182-1188.
26. Gray RH, Wawer MJ, Sewankambo NK, Serwadda D, Li C, Moulton LH, et al. Relative risks and population attributable fraction of incident HIV associated with symptoms of sexually transmitted diseases and treatable symptomatic sexually transmitted diseases in Rakai District, Uganda. AIDS 1999; 13: 2113-2123.
27. Wawer MJ, Sewankambo NK, Berkley S, Serwadda D, Musgrave SD, Gray RH, et al. Incidence of HIV-1 infection in a rural region of Uganda. BMJ 1994; 308:171-173.
28. Serwadda D, Wawer MJ, Musgrave SD, Sewankambo NK, Kaplan JE, Gray RH, et al. HIV risk factors in three geographic strata of rural Rakai District, Uganda. AIDS 1992; 6:983-989.
29. Zablotska IB, Gray RH, Koenig MA, Serwadda D, Nalugoda F, Kigozi G, et al. Alcohol use, intimate partner violence, sexual coercion and HIV among women aged 15-24 in Rakai, Uganda. AIDS Behav 2009; 13:225-233.
30. Quinn TC, Wawer MJ, Sewankambo N, Serwadda D, Li C, Wabwire-Mangen F, et al. Viral load and heterosexual transmission of human immunodeficiency virus type 1. N Engl J Med 2000; 342:921-929.
31. Morrison CS, Nanda K. Hormonal contraception and HIV: an unanswered question. Lancet Infect Dis 2012; 12:2-3.
32. Butler AR, Smith JA, Polis CB, Gregson S, Stanton D, Hallett TB. Modelling the global competing risks of a potential interaction between injectable hormonal contraception and HIV risk. AIDS 2012; 27:105-113.
33. Jain AK. Hormonal contraception and HIV acquisition risk: implications for individual users and public policies. Contraception 2012; 86:645-652.
34. Rodriguez M, Reeves M, Caughey A. Evaluating the competing risks of HIV acquisition and maternal mortality in Africa: a decision analysis. BJOG 2012; 119:1067-1073.